Hope for New Drugs Arises from the Sea
Compounds that marine creatures make to defend themselves could yield lifesaving medicines
Compounds that marine creatures make to defend themselves could yield lifesaving medicines
The antiviral Tecovirimat (TPOXX) shows promise against monkeypox, but human data and supplies are limited
A smallpox antiviral that’s effective against monkeypox is tied up in red tape, and gay-health advocates are pushing to make it easier to access
People who are unlikely to develop severe COVID-19 have no widely approved medications to ease the illness
The risks associated with hormonal contraception are lower than the risk of pregnancy itself and comparable to those of other over-the-counter drugs
Drugs such as mifepristone and misoprostol end a pregnancy, whereas the “morning-after pill” works by preventing one
The success of vaccines has reduced the pool of people available for studies, among other factors
A global look reveals contamination by antibiotics, antidepressants and other medications
An individual’s health risks, treatment access and local case levels come into play for those who are eligible
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms
Instructing our cells to make specific proteins could control influenza, autoimmune diseases, even cancer
Gum carrying a protein produced by genetically modified lettuce traps SARS-CoV-2
Different methods of drug delivery give us more tools to fight disease
MDMA, known as Ecstasy in the clubs, gained high marks in a clinical trial for PTSD
But shortages mean that new antivirals and other drugs may be hard to come by
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
For decades, assumptions about weight have clouded our view of health
A drug made by Merck and Ridgeback Biotherapeutics—which an FDA panel recently greenlit—and one made by Pfizer work in different ways, but both prevent the virus from replicating...
After long delay, U.S. President Joe Biden picks Robert Califf to once again head the U.S. Food and Drug Administration
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account